1. Home
  2. DHY vs INGN Comparison

DHY vs INGN Comparison

Compare DHY & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHY
  • INGN
  • Stock Information
  • Founded
  • DHY 1998
  • INGN 2001
  • Country
  • DHY United States
  • INGN United States
  • Employees
  • DHY N/A
  • INGN N/A
  • Industry
  • DHY Finance/Investors Services
  • INGN Industrial Specialties
  • Sector
  • DHY Finance
  • INGN Health Care
  • Exchange
  • DHY Nasdaq
  • INGN Nasdaq
  • Market Cap
  • DHY 213.4M
  • INGN 219.3M
  • IPO Year
  • DHY N/A
  • INGN 2014
  • Fundamental
  • Price
  • DHY $2.11
  • INGN $8.03
  • Analyst Decision
  • DHY
  • INGN Strong Buy
  • Analyst Count
  • DHY 0
  • INGN 3
  • Target Price
  • DHY N/A
  • INGN $11.00
  • AVG Volume (30 Days)
  • DHY 569.1K
  • INGN 180.7K
  • Earning Date
  • DHY 01-01-0001
  • INGN 11-06-2025
  • Dividend Yield
  • DHY 9.10%
  • INGN N/A
  • EPS Growth
  • DHY N/A
  • INGN N/A
  • EPS
  • DHY N/A
  • INGN N/A
  • Revenue
  • DHY N/A
  • INGN $343,472,000.00
  • Revenue This Year
  • DHY N/A
  • INGN $7.93
  • Revenue Next Year
  • DHY N/A
  • INGN $8.18
  • P/E Ratio
  • DHY N/A
  • INGN N/A
  • Revenue Growth
  • DHY N/A
  • INGN 5.15
  • 52 Week Low
  • DHY $1.77
  • INGN $5.70
  • 52 Week High
  • DHY $2.08
  • INGN $12.91
  • Technical
  • Relative Strength Index (RSI)
  • DHY 58.47
  • INGN 45.54
  • Support Level
  • DHY $2.04
  • INGN $8.24
  • Resistance Level
  • DHY $2.10
  • INGN $8.84
  • Average True Range (ATR)
  • DHY 0.02
  • INGN 0.32
  • MACD
  • DHY 0.00
  • INGN -0.08
  • Stochastic Oscillator
  • DHY 93.75
  • INGN 7.95

About DHY Credit Suisse High Yield Bond Fund

Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Share on Social Networks: